EZETIMIBE ZENTIVA 10 mg, tablet 90 tablets, CIP 3400930238943
Active ingredients: Ezetimibe
Commercialized according to BDPMDispensing in France: Prescription only
Tablet90 tablets, CIP 3400930238943orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EZETIMIBE ZENTIVA 10 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène PVDC aluminium de 90 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Sept 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60977940CIP73023894CIP133400930238943Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉZÉTIMIBEcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
- 30 tablets, CIP 3400930238806Commercialized according to BDPM
- 90 tablets, CIP 3400930238851Commercialized according to BDPM
- 30 tablets, CIP 3400930103951Commercialized according to BDPM
- 90 tablets, CIP 3400930103999Commercialized according to BDPM
- 30 tablets, CIP 3400930238905Commercialized according to BDPM
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.